Lupus and COVID vaccines: immune response under the microscope

NCT ID NCT04894253

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to understand how the COVID-19 vaccine impacts the immune system in people with lupus, a chronic autoimmune disease. Researchers planned to enroll lupus patients to measure their immune response to the vaccine and see if lupus disease activity or treatments affected that response. The study was terminated early with only 7 participants enrolled, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital of Hautepierre

    Strasbourg, Bas-Rhin, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.